Cargando…

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study

Purpose: Radiotherapy (RT) has been reported to effectively palliate many symptoms of patients with metastatic rectal cancer (mRC). The objective of this study was to evaluate the survival benefit of RT in mRC. Methods: A retrospective population-based cohort study was performed using the Surveillan...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qi, Shan, Zezhi, Luo, Dakui, Cai, Sanjun, Li, Qingguo, Li, Xinxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400677/
https://www.ncbi.nlm.nih.gov/pubmed/30854131
http://dx.doi.org/10.7150/jca.28768
_version_ 1783400000579960832
author Liu, Qi
Shan, Zezhi
Luo, Dakui
Cai, Sanjun
Li, Qingguo
Li, Xinxiang
author_facet Liu, Qi
Shan, Zezhi
Luo, Dakui
Cai, Sanjun
Li, Qingguo
Li, Xinxiang
author_sort Liu, Qi
collection PubMed
description Purpose: Radiotherapy (RT) has been reported to effectively palliate many symptoms of patients with metastatic rectal cancer (mRC). The objective of this study was to evaluate the survival benefit of RT in mRC. Methods: A retrospective population-based cohort study was performed using the Surveillance, Epidemiology, and End Results Program (SEER) database. Patient baseline demographic characteristics between the RT and no-RT groups were compared using Pearson chi-square tests. The outcome of interest was cause-specific survival (CSS). Propensity score (PS) matching and Cox proportional hazards regression analyses were performed to evaluate the prognostic power of variables on CSS. Results: A total of 8851 patients with mRC were identified in the SEER database. Multivariable Cox regression analysis showed that RT was a protective factor in mRC (hazard ratio [HR]= 0.702, 95% confidence interval [CI]=0.665-0.741, p<0.001). In subgroup analysis, multivariate Cox analysis demonstrated that patients of both surgery and no-surgery subgroups treated with RT had better CSS than those not treated with RT (HR=0.654, 95%CI=0.607-0.704, p<0.001 for the surgery group; HR=0.779, 95%CI=0.717-0.847, p<0.001 for the no-surgery group), PS matching resulted in 4170 mRC patients and RT group presented significantly improved survival benefit than no-RT group (22.0 vs. 13.5%, P <0.001). In surgery subgroup after PS matching, in especial, RT group showed more evidently improved survival benefit than no-RT group (30.3 vs. 18.0%, p <0.001). Conclusion: Using the SEER database, we definitely demonstrated that RT was associated with a significant survival advantage beyond the relief of a variety of pelvic symptoms in the setting of mRC. This study strongly supports the use of RT in selected patients with mRC, especially in patients who have undergone surgery. More studies need to be conducted to accurately define the role of RT in mRC.
format Online
Article
Text
id pubmed-6400677
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-64006772019-03-08 Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study Liu, Qi Shan, Zezhi Luo, Dakui Cai, Sanjun Li, Qingguo Li, Xinxiang J Cancer Research Paper Purpose: Radiotherapy (RT) has been reported to effectively palliate many symptoms of patients with metastatic rectal cancer (mRC). The objective of this study was to evaluate the survival benefit of RT in mRC. Methods: A retrospective population-based cohort study was performed using the Surveillance, Epidemiology, and End Results Program (SEER) database. Patient baseline demographic characteristics between the RT and no-RT groups were compared using Pearson chi-square tests. The outcome of interest was cause-specific survival (CSS). Propensity score (PS) matching and Cox proportional hazards regression analyses were performed to evaluate the prognostic power of variables on CSS. Results: A total of 8851 patients with mRC were identified in the SEER database. Multivariable Cox regression analysis showed that RT was a protective factor in mRC (hazard ratio [HR]= 0.702, 95% confidence interval [CI]=0.665-0.741, p<0.001). In subgroup analysis, multivariate Cox analysis demonstrated that patients of both surgery and no-surgery subgroups treated with RT had better CSS than those not treated with RT (HR=0.654, 95%CI=0.607-0.704, p<0.001 for the surgery group; HR=0.779, 95%CI=0.717-0.847, p<0.001 for the no-surgery group), PS matching resulted in 4170 mRC patients and RT group presented significantly improved survival benefit than no-RT group (22.0 vs. 13.5%, P <0.001). In surgery subgroup after PS matching, in especial, RT group showed more evidently improved survival benefit than no-RT group (30.3 vs. 18.0%, p <0.001). Conclusion: Using the SEER database, we definitely demonstrated that RT was associated with a significant survival advantage beyond the relief of a variety of pelvic symptoms in the setting of mRC. This study strongly supports the use of RT in selected patients with mRC, especially in patients who have undergone surgery. More studies need to be conducted to accurately define the role of RT in mRC. Ivyspring International Publisher 2019-01-29 /pmc/articles/PMC6400677/ /pubmed/30854131 http://dx.doi.org/10.7150/jca.28768 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Liu, Qi
Shan, Zezhi
Luo, Dakui
Cai, Sanjun
Li, Qingguo
Li, Xinxiang
Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
title Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
title_full Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
title_fullStr Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
title_full_unstemmed Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
title_short Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
title_sort palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: a large us population-based and propensity score-matched study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400677/
https://www.ncbi.nlm.nih.gov/pubmed/30854131
http://dx.doi.org/10.7150/jca.28768
work_keys_str_mv AT liuqi palliativebeamradiotherapyofferedrealworldsurvivalbenefittometastaticrectalcanceralargeuspopulationbasedandpropensityscorematchedstudy
AT shanzezhi palliativebeamradiotherapyofferedrealworldsurvivalbenefittometastaticrectalcanceralargeuspopulationbasedandpropensityscorematchedstudy
AT luodakui palliativebeamradiotherapyofferedrealworldsurvivalbenefittometastaticrectalcanceralargeuspopulationbasedandpropensityscorematchedstudy
AT caisanjun palliativebeamradiotherapyofferedrealworldsurvivalbenefittometastaticrectalcanceralargeuspopulationbasedandpropensityscorematchedstudy
AT liqingguo palliativebeamradiotherapyofferedrealworldsurvivalbenefittometastaticrectalcanceralargeuspopulationbasedandpropensityscorematchedstudy
AT lixinxiang palliativebeamradiotherapyofferedrealworldsurvivalbenefittometastaticrectalcanceralargeuspopulationbasedandpropensityscorematchedstudy